Quick viewing(Text Mode)

Federal Register/Vol. 68, No. 118/Thursday, June 19

Federal Register/Vol. 68, No. 118/Thursday, June 19

Federal Register / Vol. 68, No. 118 / Thursday, June 19, 2003 / Notices 36841

U.S. Department of Justice, Washington, DEPARTMENT OF JUSTICE the basic classes of Schedule I and II DC 20044–7611 or by faxing or e- controlled substances listed below: mailing a request to Tonia Fleetwood Drug Enforcement Administration ([email protected]), fax no. (202) 514–0097, phone confirmation Manufacturer of Controlled number (202) 514–1547. In requesting a Substances; Notice of Application copy from the Consent Decree Library, please enclose a check in the amount of Pursuant to section 1301.33(a) of title $51.00 (25 cents per page reproduction 21 of the Code of Federal Regulations cost) payable to the U.S. Treasury. (CFR), this is notice that on February 19, 2003, AccuStandard Inc., 125 Market William D. Brighton, Street, New Haven, Connecticut 06513, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources made application by renewal and on Division. May 7, 2003, by letter, to the Drug [FR Doc. 03–15440 Filed 6–18–03; 8:45 am] Enforcement Administration (DEA) for BILLING CODE 4410–15–M registration as a bulk manufacturer of

Drug Schedule

Cathinone (1235) ...... I Methcathinone (1237) ...... I N-Ethylamphetamine (1475) ...... I N,N-Dimethylamphetamine (1480) ...... I Fenethylline (1503) ...... I Aminorex (1585) ...... I 4-Methylaminorex (cis isomer) ...... I Gamma hydroxybutyric acid (2010) ...... I Methaqualone (2565) ...... I Mecloqualone (2572) ...... I Alpha-Ethyltryptamine (7249) ...... I (7260) ...... I Lysergic acid diethylamide (7315) ...... I (7370) ...... I Mescaline (7381) ...... I 3,4,5-Trimethoxyamphetamine (7390) ...... I 4-Bromo-2,5-dimethoxyamphetamine (7391) ...... I 4-Bromo-2,5-dimethoxyamphetamine (7392) ...... I 4-Methyl-2,5-dimethoxyamphetamine (7395) ...... I 2,5-Dimethoxyamphetamine (7396) ...... I 2,5-Dimethoxy-4-ethylamphetamine (7399) ...... I 3,4-Methylenedioxyamphetamine (7400) ...... I 5-Methoxy-3,4-methylenedioxyamphetamine (7401) ...... I N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ...... I 3,4-Methylenedioxy-N-ethylamphetamine (7404) ...... I 3,4-Methylenedioxymethamphetamine (7405) ...... I 4-Methoxyamphetamine (7411) ...... I Bufotenine (7433) ...... I Diethyltryptamine (7434) ...... I Dimethyltryptamine (7435) ...... I Psilocybin (7437) ...... I Psilocyn (7438) ...... I N-Ethyl-1-phenylcyclohexylamine (7455) ...... I 1-(1-Phenylcyclohexyl) pyrrolidine (PCPY) (7458) ...... I 1-[1-(2-Thienyl) cyclohexyl] piperidine (7470) ...... I 1-[1-(2-Thienyl) cyclohexyl] pyrrolidine (TCPY) (7473) ...... I N-Ethyl-3-piperidyl benzilate (7482) ...... I N-Methyl-3-Piperidyl benzilate (7484) ...... I (9051) ...... I (9052) ...... I -N-oxide (9053) ...... I (9054) ...... I (9055) ...... I (except HCL) (9056) ...... I Codeine methylbromide (9070) ...... I (9145) ...... I Difenoxin (9168) ...... I (9200) ...... I (9301) ...... I Methyldesorphine (9302) ...... I Methyldihydromorphine (9304) ...... I methylbromide (9305) ...... I Morphine methylsulfonate (9306) ...... I Morphine-N-oxide (9307) ...... I Myrophine (9308) ...... I

VerDate Jan<31>2003 16:23 Jun 18, 2003 Jkt 200001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1 36842 Federal Register / Vol. 68, No. 118 / Thursday, June 19, 2003 / Notices

Drug Schedule

Nicocodeine (9309) ...... I (9312) ...... I Normorphine (9313) ...... I Pholcodine (9314) ...... I Thebacon (9315) ...... I Acetorphine (9319) ...... I Drotebanol (9335) ...... I Acetylmethadol (9601) ...... I Allylprodine (9602) ...... I Alphacetylmethadol except levo-alphacetylmethadol (9603) ...... I Alphameprodine (9604) ...... I Alphamethadol (9605) ...... I Benzethidine (9606) ...... I Betacetylmethadol (9607) ...... I Betameprodine (9608) ...... I Betamethadol (9609) ...... I Betaprodine (9611) ...... I Clonitazene (9612) ...... I (9613) ...... I Diampromide (9615) ...... I Diethylthiambutene (9616) ...... I (9617) ...... I Dimepheptanol (9618) ...... I Dimethylthiambutene (9619) ...... I Dioxaphetyl butyrate (9621) ...... I (9622) ...... I Ethylmethylthiambutene (9623) ...... I Etonitazene (9624) ...... I Etoxeridine (9625) ...... I Furethidine (9626) ...... I Hydroxypethidine (9627) ...... I (9628) ...... I Levomoramide (9629) ...... I Levophenacylmorphan (9631) ...... I Morpheridine (9632) ...... I Noracymethadol (9633) ...... I Norlevorphanol (9634) ...... I Normethadone (9635) ...... I Norpipanone (9636) ...... I Phenadoxone (9637) ...... I Phenampromide (9638) ...... I Phenoperidine (9641) ...... I (9642) ...... I Proheptazine (9643) ...... I Properidine (9644) ...... I Racemoramide (9645) ...... I Trimeperidine (9646) ...... I Phenomorphan (9647) ...... I (9649) ...... I 1-Methyl-4-phenyl-4-propionoxypiperidine (9661) ...... I 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (9663) ...... I (9750) ...... I Para-Fluorofentanyl (9812) ...... I 3-Methylfentanyl (9813) ...... I Alpha-Methylfentanyl (9814) ...... I Acetyl-alpha-methylfentanyl (9815) ...... I Benzylfentanyl (9818) ...... I Beta-Hydroxyfentanyl (9830) ...... I Beta-Hydroxy-3-methylfentanyl (9831) ...... I Alpha-Methylthiofentanyl (9832) ...... I 3-Methylthiofentanyl (9833) ...... I Thenylfentanyl (9834) ...... I Thiofentanyl (9835) ...... I Amphetamine (1100) ...... II Methamphetamine (1105) ...... II Phenmetrazine (1631) ...... II Methylphenidate (1724) ...... II Amobarbital (2125) ...... II Pentobarbital (2270) ...... II Secobarbital (2315) ...... II Glutethimide (2550) ...... II Nabilone (7379) ...... II 1-Phenylcylohexylamine (7460) ...... II (7471) ...... II

VerDate Jan<31>2003 16:23 Jun 18, 2003 Jkt 200001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1 Federal Register / Vol. 68, No. 118 / Thursday, June 19, 2003 / Notices 36843

Drug Schedule

Phenylacetone (8501) ...... II 1-Piperidinocyclohexanecarbonitrile (8603) ...... II Alphaprodine (9010) ...... II (9020) ...... II Cocaine (9041) ...... II Codeine (9050) ...... II (9058) ...... II Etorphine HCL (9059) ...... II (9120) ...... II (9143) ...... II (9150) ...... II (9170) ...... II Benzoylecgonine (9180) ...... II Ecgonine (9180) ...... II (9190) ...... II (9193) ...... II (9210) ...... II (9220) ...... II (9226) ...... II Meperidine (9230) ...... II Meperidine intermediate-A (9232) ...... II Meperidine intermediate-B (9233) ...... II Meperidine intermediate-C (9234) ...... II (9240) ...... II (9250) ...... II Methadone intermediate (9254) ...... II (9260) ...... II Morphine (9300) ...... II (9333) ...... II (9334) ...... II , raw (9600) ...... II Opium tincture (9630) ...... II Opium powdered (9639) ...... II Levo-alphacetylmethadol (9648) ...... II (9652) ...... II (9715) ...... II (9730) ...... II Racemethorphan (9732) ...... II (9733) ...... II (9737) ...... II (9739) ...... II (9740) ...... II (9743) ...... II (9800) ...... II Fentalyl (9801) ...... II Moramide-intermediate (9802) ...... II

The firm plans to manufacture small Dated: June 6, 2003. Administration by renewal to the Drug quantities of bulk material for use in Laura M. Nagel, Enforcement Administration (DEA) for reference standards. Deputy Assistant Administrator, Office of registration as a bulk manufacturer of Any other such applicant and any Diversion Control, Drug Enforcement Methylphenidate (1724), a basic class of Administration. person who is presently registered with controlled substances listed in Schedule [FR Doc. 03–15534 Filed 6–18–03; 8:45 am] II. DEA to manufacture such substances may file comments or objections to the BILLING CODE 4410–09–M The firm plans to manufacture the issuance of the proposed registration. listed controlled substance to make finished dosage forms for distribution to Any such comments or objections DEPARTMENT OF JUSTICE its customers. may be addressed, in quintuplicate, to Drug Enforcement Administration Any other such applicant and any the Deputy Assistant Administrator, person who is presently registered with Office of Diversion Control, Drug Manufacturer of Controlled DEA to manufacture such substances Enforcement Administration, United Substances; Notice of Application may file comments or objections to the States Department of Justice, issuance of the proposed registration. Washington, DC 20537, Attention: DEA Pursuant to § 1301.33(a) of title 21 of Any such comments or objections Federal Register Representative (CCD) the Code of Federal Regulations (CFR), may be addressed, in quintuplicate, to and must be filed no later than August this is notice that on—January 28, 2003, the Deputy Assistant Administrator, 18, 2003. CellTech Manufacturing CA., Inc., 3501 Office of Diversion Control, Drug West Garry Avenue, Santa Ana, Enforcement Administration, United California 92704, made application by States Department of Justice, renewal to the Drug Enforcement Washington, DC 20537, Attention:

VerDate Jan<31>2003 16:23 Jun 18, 2003 Jkt 200001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1

Top View